This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Janssen Biotech, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Olav Lyngberg: Biopharmaceutical Invention and Bioreactor Manufacturing
Introduction
Olav Lyngberg is an inventor associated with Raritan, New Jersey, and Janssen Biotech, Inc. His work includes a patented approach to analyzing and controlling glycation and glycan structures in biopharmaceutical manufacturing.
Latest Patents
Lyngberg is credited with 1 patent: “Multiparameter Materials, Methods and Systems for Enhanced Bioreactor Manufacture.” The patent describes methods for assessing glycation on a molecule and glycan structures on glycosylated molecules by combining spectroscopic analysis with chemometric modeling. It also covers methods and systems for producing molecules with desired levels of glycation, including non-glycated molecules, and desired glycan structures.
Career Highlights
Lyngberg’s listed patent connects analytical techniques with bioreactor production, addressing how molecular characteristics can be measured and controlled during manufacturing. His company affiliation is Janssen Biotech, Inc.
Collaborations
The supplied information identifies Caitlin O’Mahony-Hartnett and Barry J. McCarthy as Lyngberg’s coworkers. Their names are provided as professional associations, though specific joint work on the patent is not established by the available details.
Conclusion
Olav Lyngberg’s patent reflects an effort to improve biopharmaceutical manufacturing through measurement and control of glycation and glycan structures.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile